Navigation Links
Silicon Logic Engineering Ramps Up Custom Chips
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Silicon Logic Engineering Ramps Custom Chips

(Date:12/14/2009)... Resources, one of the world,s leading research and ... that, owing to the launches of several new ... more than sevenfold from $790 million in 2008 ... States, France, Germany, Italy, Spain, the United Kingdom ... Atrial Fibrillation finds that a strong ...
(Date:12/11/2009)... -- Dendreon Corporation (Nasdaq: DNDN ) announced ... public offering have exercised in full their option ... stock at the public offering price of $24.75 ... increases the size of the offering to an ... Dendreon expects to receive net proceeds from the ...
(Date:12/11/2009)... Dec. 11 Ambit Biosciences Corporation announced today ... M. D. Anderson Cancer Center of the first patient ... E fficacy) Phase 2 pivotal trial ... (AML). AC220 is a novel, orally available, potent ... as a FMS-like tyrosine kinase-3 (FLT3) inhibitor. The ...
(Date:12/11/2009)... CALGARY, Dec. 11 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ... today announced the appointment of Dr. Alan Warrander ... Licensing and Business Development. ,, "Dr. Warrander will ... licensing strategy for REOLYSIN(R)," said Dr. Brad Thompson, ... agreement on the design of a Phase 3 ...
Breaking Biology Technology:The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3
... Switzerland, May 16 Arpida Ltd.,(SWX: ARPN) today announced ... for review the New Drug Application (NDA) for,intravenous iclaprim ... (cSSSI). Arpida completed the submission of the NDA to,the ... ten month review to,the iclaprim NDA and has established ...
... UC Davis have shown that they can use a ... atomic force microscope. , "It turns around the rules ... said Volkmar Heinrich, assistant professor in the Department of ... paper with graduate student Chawin Ounkomol. , An atomic ...
... Calif., May 15 NeurogesX, Inc.,(Nasdaq: NGSX ... management therapies, announced today that it is scheduled ... Rodman & Renshaw 5th Annual Global,Healthcare Conference. Anthony ... and Stephen Ghiglieri, Chief Financial Officer,will be available ...
Other Biology Technology:Arpida Announces FDA Acceptance of the Iclaprim New Drug Application 2Arpida Announces FDA Acceptance of the Iclaprim New Drug Application 3NeurogesX to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference 2NeurogesX to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference 3
(Date:12/11/2009)... the global "green" trend, educators worldwide are ... enhance students, science knowledge. Studies have revealed ... raises not just science scoresenvironmental-based lessons can ... subject areas. Naturally, educators are interested in ... lessons into the classroom in hopes of ...
(Date:12/11/2009)... weigh and initiate different survival strategies say they have ... that affect their health, wealth and the fate of ... in the early online edition of the journal ... accomplished when the scientists applied the mathematical techniques used ... and proteins that colonies of bacteria rely upon to ...
(Date:12/11/2009)... , Montreal, December 11, 2009 Canadian ... cancer. In the December 11 edition of the prestigious ... de Montral and the Universit de Sherbrooke explain how ... activity of cytokines, hormones that are culprits in cancer-prone ... people exposed to asbestos. , "Excessive cytokine activity ...
Breaking Biology News(10 mins):Students learn environmental stewardship, improve science scores 2Bacteria provide new insights into human decision making 2Bacteria provide new insights into human decision making 3Bacteria provide new insights into human decision making 4Bacteria provide new insights into human decision making 5Scientists identify natural anti-cancer defenses 2Queens University study aims at early diagnosis for ADHD and Parkinsons disease 51513 1Queens University study aims at early diagnosis for ADHD and Parkinsons disease 51513 2Cant Text Im Driving 21 51509 1Cant Text Im Driving 21 51509 2HIMSS Electronic Health Record Association Supports Achievable Meaningful Use Criteria in Comments to ONC 51504 1HIMSS Electronic Health Record Association Supports Achievable Meaningful Use Criteria in Comments to ONC 51504 2HIMSS Electronic Health Record Association Supports Achievable Meaningful Use Criteria in Comments to ONC 51504 3
... and Biological Sciences Research Council (BBSRC) could lead to ... bones and other orthopaedic problems associated with ageing. , ... universities of Keele, Imperial College London, Nottingham and Southampton ... and tissue engineering to look at the development and ...
... emerging form of the pathogenic yeast Candida is ... tube, even though it,s missing the genes for reproduction. And ... Duke University Medical Center researchers. , "Sex contributes ... success," said Joseph Heitman, M.D., Ph.D., director of the Center ...
... former President of the Deutsche Forschungsgemeinschaft (DFG, German ... Rising Sun, Gold Rays with Neck Ribbon in ... service to scientific cooperation between Japan and Germany ... Professor Winnacker received the Order, together with other ...
Other Biology News:Award for pioneering stem cell research to mend broken bones 2Yeast missing sex genes undergo unexpected sexual reproduction 2Ernst-Ludwig Winnacker awarded the Order of the Rising Sun 2Ernst-Ludwig Winnacker awarded the Order of the Rising Sun 3
...
... Platform combines robust chemistry with optimized ... specific, and cost-effective detection method available ... offers exceptional performance with specificity and ... signal/background ratio, and an expanded array ...
Provides continuous mixing action. For use with tubes, vials, and other containers...
... via cardiac puncture from 3 to 4 week ... is then centrifuged and frozen at -70C. The ... at 4C then stored at -70C. DIRECT SALES ... PEL-FREEZ COMPLEMENT, YOU CAN NOW BUY DIRECTLY FROM ...
Biology Products: